Role of butyric acid and its derivatives in the treatment of colorectal cancer and hemoglobinopathies
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 63 (20) , 1739-1760
- https://doi.org/10.1016/s0024-3205(98)00279-3
Abstract
No abstract availableKeywords
This publication has 159 references indexed in Scilit:
- Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cellsZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Butyrate enhances major histocompatibility complex class I, HLA‐DR and ICAM‐1 antigen expression on differentiated human intestinal epithelial cellsEuropean Journal of Clinical Investigation, 1996
- Among 17 inducers of differentiation only sodium butyrate causes a permanent down-regulation ofc-myc in Burkitt's lymphomaInternational Journal of Cancer, 1995
- Selective Induction of Apoptosis in Myeloid Leukemic Cell Lines by Monoacetone Glucose-3 ButyrateBiochemical and Biophysical Research Communications, 1994
- Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrateBiochemistry, 1992
- Derivatives of butyric acid as potential anti‐neoplastic agentsInternational Journal of Cancer, 1991
- Hematologic Responses of Patients with Sickle Cell Disease to Treatment with HydroxyureaNew England Journal of Medicine, 1990
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Antibody-mediated targeting of differentiation inducers to tumor cells: Inhibition of colonic cancer cell growth in vitro and in vivo a preliminary noteBiochemical and Biophysical Research Communications, 1989
- Treatment of Episodic Hyperammonemia in Children with Inborn Errors of Urea SynthesisNew England Journal of Medicine, 1984